SBC Medical Valuation
| SBCWW Stock | 0.26 0.01 3.70% |
SBC Medical seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of SBC Medical Group from evaluating the entity technical indicators and probability of bankruptcy. In general, investors recommend buying undervalued stocks and disposing overvalued stocks since, in the future, stock prices and their ongoing real values will merge together.
Overvalued
Today
Please note that SBC Medical's price fluctuation is out of control at this time. Calculation of the real value of SBC Medical Group is based on 3 months time horizon. Increasing SBC Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the SBC stock is determined by what a typical buyer is willing to pay for full or partial control of SBC Medical Group. Since SBC Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of SBC Stock. However, SBC Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.26 | Real 0.19 | Hype 0.17 |
The intrinsic value of SBC Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence SBC Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of SBC Medical Group helps investors to forecast how SBC stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of SBC Medical more accurately as focusing exclusively on SBC Medical's fundamentals will not take into account other important factors: SBC Medical Total Value Analysis
SBC Medical Group is at this time anticipated to have takeover price of 0 with market capitalization of 0, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the SBC Medical fundamentals before making investing decisions based on enterprise value of the companySBC Medical Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of SBC indicates not a very effective usage of assets in December.About SBC Medical Valuation
Our relative valuation model uses a comparative analysis of SBC Medical. We calculate exposure to SBC Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of SBC Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 137.3 M | 138.7 M |
Additional Tools for SBC Stock Analysis
When running SBC Medical's price analysis, check to measure SBC Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SBC Medical is operating at the current time. Most of SBC Medical's value examination focuses on studying past and present price action to predict the probability of SBC Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SBC Medical's price. Additionally, you may evaluate how the addition of SBC Medical to your portfolios can decrease your overall portfolio volatility.